The protection of Trpm7R/R mice from GVHD, we have shown, unravels the clinical relevance of TRPM7 kinase as a target for limiting TGF-β-dependent CD103 expression as a pathogenetic mechanism in intestinal destruction during GVHD27. This evidence concerns the gene ITGAE and graft versus host disease.